🇺🇸 Kenacort A, in United States

100 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 100

Most-reported reactions

1. Intentional Product Use Issue — 17 reports (17%)
2. Off Label Use — 17 reports (17%)
3. Arthralgia — 10 reports (10%)
4. Endophthalmitis — 9 reports (9%)
5. Oesophageal Perforation — 9 reports (9%)
6. Pain — 9 reports (9%)
7. Eyelid Ptosis — 8 reports (8%)
8. Drug Ineffective — 7 reports (7%)
9. Product Use In Unapproved Indication — 7 reports (7%)
10. Pyrexia — 7 reports (7%)

Source database →

Frequently asked questions

Is Kenacort A, approved in United States?

Kenacort A, does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Kenacort A, in United States?

Jaylane kadry Ghonima is the originator. The local marketing authorisation holder may differ — check the official source linked above.